Skip to content

Clinical observation of the possible effects of nalmefene combined with sufentanil in the recovery period of uvulopalatopharyngoplasty

Clinical observation of the possible effects of nalmefene combined with sufentanil in the recovery period of uvulopalatopharyngoplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055823
Enrollment
Unknown
Registered
2022-01-20
Start date
2021-04-10
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory depression

Interventions

N group:nalmefene + sufentanil

Sponsors

Department of Anesthesiology, Zhongda Hospital, Southeast University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adult male patients aged 18 to 65 years; 2. ASA grade I - II; 3. All surgical patients signed informed consent.

Exclusion criteria

Exclusion criteria: 1. History of opioid allergy or abuse; 2. Patients with abnormal liver and kidney function (alanine aminotransferase > 100u / L, aspartate aminotransferase > 100u / L, creatinine > 100umol / L); 3. Patients with hematological diseases or other hemorrhagic diseases; 4. Patients with a history of chronic obstructive pulmonary disease or severe asthma (need daily drug control or attack in the last month); 5. Patients with myasthenia gravis or other neuromuscular diseases; 6. Patients who cannot understand the significance of visual analog score (VAS); 7. Preoperative and intraoperative decision to bring the tube back to ICU patients after operation; 8. Contraindication of uvulopalatopharyngoplasty.

Design outcomes

Primary

MeasureTime frame
Incidence of respiratory depression;visual analogue scale (VAS) after extubation;Ramsay score after extubation;

Countries

China

Contacts

Public ContactWang Jin

Zhongda Hospital Affiliated to Southeast University

wangjin7980@126.com+86 13813860408

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026